Mariola López
About
Mariola López is a scholar working on Virology, Immunology and Epidemiology.
According to data from OpenAlex, Mariola López has authored 39 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Virology, 18 papers in Immunology and 14 papers in Epidemiology. Recurrent topics in Mariola López's work include HIV Research and Treatment (26 papers), Immune Cell Function and Interaction (16 papers) and HIV-related health complications and treatments (10 papers). Mariola López is often cited by papers focused on HIV Research and Treatment (26 papers), Immune Cell Function and Interaction (16 papers) and HIV-related health complications and treatments (10 papers). Mariola López collaborates with scholars based in Spain, United States and Singapore. Mariola López's co-authors include Vincent Soriano, José M. Benito, Juan González‐Lahoz, Sara Lozano, Javier García‐Samaniego, Norma Rallón, Eulalia Valencia, Luz Martı́n-Carbonero, Eugenia Vispo and Berta Rodés and has published in prestigious journals such as The Journal of Immunology, Clinical Infectious Diseases and The Journal of Infectious Diseases.
In The Last Decade
Mariola López
38 papers receiving 906 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mariola López Spain | 19 | 503 | 366 | 363 | 336 | 245 | 39 | 950 | ||
| Norma Rallón Spain | 22 | 550 1.1× | 620 1.7× | 402 1.1× | 429 1.3× | 638 2.6× | 99 | 1.4k | ||
| Patricia Baré Argentina | 16 | 172 0.3× | 228 0.6× | 198 0.5× | 173 0.5× | 226 0.9× | 46 | 665 | ||
| Miguel Genebat Spain | 19 | 552 1.1× | 263 0.7× | 376 1.0× | 331 1.0× | 85 0.3× | 55 | 902 | ||
| Elisa De Crignis Italy | 16 | 712 1.4× | 173 0.5× | 359 1.0× | 503 1.5× | 50 0.2× | 28 | 1.2k | ||
| George F. Gjerset United States | 6 | 451 0.9× | 151 0.4× | 366 1.0× | 155 0.5× | 34 0.1× | 8 | 653 | ||
| Camille Lécuroux France | 19 | 707 1.4× | 174 0.5× | 395 1.1× | 478 1.4× | 25 0.1× | 33 | 935 | ||
| Natalia Laufer Argentina | 17 | 344 0.7× | 299 0.8× | 233 0.6× | 260 0.8× | 208 0.8× | 61 | 757 | ||
| Wang Hj China | 7 | 257 0.5× | 190 0.5× | 157 0.4× | 138 0.4× | 61 0.2× | 12 | 484 | ||
| Marie‐Paule Schmitt France | 13 | 304 0.6× | 298 0.8× | 273 0.8× | 113 0.3× | 203 0.8× | 20 | 643 | ||
| Megan Crane Australia | 12 | 138 0.3× | 424 1.2× | 209 0.6× | 59 0.2× | 314 1.3× | 23 | 626 |
Countries citing papers authored by Mariola López
Since
Specialization
Citations
This map shows the geographic impact of Mariola López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariola López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariola López more than expected).
Fields of papers citing papers by Mariola López
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Mariola López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariola López. The network helps show where Mariola López may publish in the future.
Co-authorship network of co-authors of Mariola López
This figure shows the co-authorship network connecting the top 25 collaborators of Mariola López. A scholar is included among the top collaborators of Mariola López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariola López. Mariola López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Aznar, María Luisa, et al.. (2025). Identificación de linajes y sublinajes del complejo Mycobacterium tuberculosis mediante estrategias moleculares avanzadas y secuenciación en Sevilla, España (2015-2022). Enfermedades Infecciosas y Microbiología Clínica. 44(1). 503038–503038.
2.
Vispo, Eugenia, Pablo Barreiro, José Vicente Fernández-Montero, et al.. (2014). Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy. AIDS. 28(10). 1473–1478.
3.
Masiá, Mar, Santiago Pérez Cachafeiro, María Leyes, et al.. (2012). Riesgo cardiovascular en pacientes con infección por el virus de la inmunodeficiencia humana en España. Cohorte CoRIS, 2011. Enfermedades Infecciosas y Microbiología Clínica. 30(9). 517–527.
4.
López, Mariola, et al.. (2011). Short Communication High Risk of Endothelial Dysfunction in HIV Individuals May Result from Deregulation of Circulating Endothelial Cells and Endothelial Progenitor Cells. AIDS Research and Human Retroviruses. 28(7). 656–659.
5.
Salgado, María, Norma Rallón, Berta Rodés, et al.. (2011). Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors. Clinical Immunology. 139(2). 110–114.
6.
López, Mariola, Vincent Soriano, Sara Lozano, et al.. (2011). The expansion ability but not the quality of HIV-specific CD8+ T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors. Immunology. 134(3). 305–313.
7.
Salgado, María, Pedro López‐Romero, Sergio Callejas, et al.. (2011). Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression. Virology. 411(1). 103–112.
8.
Rallón, Norma, et al.. (2011). Longitudinal Assessment of Interleukin 7 Plasma Levels in HIV-Infected Patients in the Absence of and Under Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(5). 436–441.
9.
Rallón, Norma, Pablo Barreiro, Vincent Soriano, et al.. (2010). Elevated TGF‐β1 levels might protect HCV/ HIV‐coinfected patients from liver fibrosis. European Journal of Clinical Investigation. 41(1). 70–76.
10.
López, Mariola, et al.. (2010). Elite Controllers Display Higher Activation on Central Memory CD8 T Cells Than HIV Patients Successfully on HAART. AIDS Research and Human Retroviruses. 27(2). 157–165.
11.
Salgado, María, Norma Rallón, Mariola López, et al.. (2010). An Additive Effect of Protective Host Genetic Factors Correlates With HIV Nonprogression Status. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(4). 300–305.
12.
López, Mariola, Vincent Soriano, Sara Lozano, et al.. (2008). No Major Differences in the Functional Profile of HIV Gag and Nef-Specific CD8 + Reponses between Long-Term Nonprogressors and Typical Progressors. AIDS Research and Human Retroviruses. 24(9). 1185–1195.
13.
López, Mariola, Norma Rallón, Vincent Soriano, et al.. (2008). Short Communication: HIV Rebound after Discontinuation of Antiretroviral Therapy Increases and Expands HIV-Specific CD8 + Responses But Has No Impact on Its Functionality. AIDS Research and Human Retroviruses. 24(9). 1197–1201.
14.
López, Mariola, Vincent Soriano, Norma Rallón, et al.. (2008). Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV‐specific CD8+ T cells. European Journal of Immunology. 38(6). 1548–1558.
15.
López, Mariola, Carlos Toro, Victoria Jiménez, et al.. (2006). Influence of Human T Cell Lymphotropic Virus Type 2 Coinfection on Virological and Immunological Parameters in HIV Type 1–Infected Patients. Clinical Infectious Diseases. 44(1). 105–110.
16.
López, Mariola, et al.. (2006). Impact of Gag Sequence Variability on Level, Phenotype, and Function of Anti-HIV Gag-Specific CD8 + Cytotoxic T Lymphocytes in Untreated Chronically HIV-Infected Patients. AIDS Research and Human Retroviruses. 22(9). 884–892.
17.
Jc, Martín, Jesús Castilla, Mariola López, et al.. (2004). Impact of Chronic Hepatitis C on HIV-1 Disease Progression. HIV Clinical Trials. 5(3). 125–131.
18.
Benito, José M., et al.. (2004). CD38 Expression on CD8 T Lymphocytes as a Marker of Residual Virus Replication in Chronically HIV-Infected Patients Receiving Antiretroviral Therapy. AIDS Research and Human Retroviruses. 20(2). 227–233.
19.
Benito, José M., Mariola López, Martín Jc, et al.. (2002). Differences in Cellular Activation and Apoptosis in HIV-Infected Patients Receiving Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors. AIDS Research and Human Retroviruses. 18(18). 1379–1388.
20.
Martı́n-Carbonero, Luz, Vincent Soriano, Eulalia Valencia, et al.. (2001). Increasing Impact of Chronic Viral Hepatitis on Hospital Admissions and Mortality among HIV-Infected Patients. AIDS Research and Human Retroviruses. 17(16). 1467–1471.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Norma Rallón Breakdown of academic impact, for papers by Patricia Baré Breakdown of academic impact, for papers by Miguel Genebat Breakdown of academic impact, for papers by Elisa De Crignis Breakdown of academic impact, for papers by George F. Gjerset Breakdown of academic impact, for papers by Camille Lécuroux Breakdown of academic impact, for papers by Natalia Laufer Breakdown of academic impact, for papers by Wang Hj Breakdown of academic impact, for papers by Marie‐Paule Schmitt Breakdown of academic impact, for papers by Megan Crane